Brief: Lumos Pharma Reports First Quarter 2022 Financial Results And Clinical Development Updates
10/05/2022 22:28
May 10 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
CLINICAL DEVELOPMENT UPDATES
* ENDED QUARTER ON MARCH 31, 2022 WITH CASH AND CASH
EQUIVALENTS
TOTALING $86.8 MILLION
* EXPECTS AN AVERAGE CASH USE OF APPROXIMATELY $8.5 TO $9.5
MILLION PER QUARTER THROUGH 2022
* Q1 EARNINGS PER SHARE VIEW $-0.89 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX93nhFf
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)